Healthcare
LSP et al. back Imcyse in €35m series-B
New and historical backers invest in Belgium-based Imcyse, a developer of immunotherapies
VC firms back €65m financing for BioSerenity
Fresh capital will be used to develop BioSerenity's products beyond their initial focus
Nordic Capital announces NY base for US healthcare push
Initiative is being led by healthcare co-head Raj Shah and healthcare partner Thomas Vetander
ADC Therapeutics gathers $76m in series-E extension
Headquartered in Lausanne, ADC Therapeutics has raised $531m since its inception in 2012
Corpfin-backed Grupo 5 sells six nursing homes to Korian
Partial exit for Corpfin, which bought a 98% stake in Grupo 5 in 2017 via its fourth fund
Advent backs Spanish dental group Vitaldent
GP intends to accelerate the company's organic growth and strengthen its market position
New opportunities flourish in Italian healthcare
Sector has seen intense activity in recent years, with a noticeable increase in both deal volume and value
Nazca buys biopharmaceutical company Diater in €45m deal
This is the fifth investment made by Nazca Fund IV, which closed on €275m in 2017
Investindustrial-backed Lifebrain buys clinical lab Galeno
Galeno will be integrated within the Lifebrain business and will consolidate its market position
Waterland-backed Rehacon bolts on Fysioconcept
Waterland acquired a majority stake in physiotherapy provider Rehacon in January 2019
Duke Street backs MBO of Kent and Athlone from DCC
UK and Irish businesses will form the basis for a buy-and-build growth strategy
CVC-backed Synsam postpones IPO – reports
CVC acquired the business in 2014, drawing equity from CVC European Equity Partners V
Ampersand to acquire Vibalogics
Ampersand typically invests $10-50m in companies with $10-100m in annual revenues
Steadfast Capital to buy W Söhngen
Steadfast will use its fourth vehicle for the investment in the medicine products manufacturer
Livingbridge exits Create Fertility in management buy-back
Sale ends a six-year holding period for the GP, which invested ТЃ5m in the company for a minority
Seventure Partners invests €3.5m in Domain Therapeutics
Paris-based VC typically provides up to €20m per company, from early to late stage
Creandum leads £10m series-A for life insurance app Yulife
MMC Ventures, Notion Capital, LocalGlobe and Anthemis Ventures also take part in the round
Ekkio backs Mediliant
Mediliant is the fourth investment completed via Ekkio Capital IV, closed in May 2018
Ardian acquires Sintetica
In 2018, Sintetica reported revenues of CHF 75m, up from approximately CHF 60m in 2017
TA Associates' Solabia Group buys Algatech
TA has been a minority investor in natural active ingredients manufacturer Solabia since 2018
ArchiMed carves out Diesse from PZ Cormay
Diesse was acquired from Orphée, the Swiss subsidiary of Warsaw-listed diagnostics group PZ Cormay
Sofinnova closes MD Start III Fund on €48m
MD Start, which is a group of three funds, was started by Sofinnova Partners in 2010
VCs invest £14m in Storm Therapeutics
Storm Therapeutics has now raised more than ТЃ30m in capital from its new and existing investors
Syncona leads £35m series-A for Quell
UCL Technology Fund also took part in the round for the newly launched cell therapy company